Zacks Investment ResearchMon, 04 May 2026 15:06:22 GMTBioXcel Therapeutics, Inc. (BTAI) Expected to Beat Earnings Estimates: Should You Buy?BTAI-1.61%
Seeking AlphaFri, 24 Apr 2026 14:31:34 GMTBioXcel Therapeutics, Inc. (BTAI) Discusses Commercial Launch Strategy and Market Opportunity for IGALMI in At-Home Setting TranscriptBTAI-1.61%
BenzingaThu, 05 Mar 2026 13:53:51 GMTBioXcel Therapeutics Stock Rallies Opioid Study SuccessBTAI-1.61%
Seeking AlphaFri, 27 Feb 2026 23:07:49 GMTBioXcel Therapeutics, Inc. (BTAI) Discusses Phase III Results and Advances in Treating Acute Agitation in Alzheimer's Dementia TranscriptBTAI-1.61%